Cargando…

Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study

BACKGROUND: Insulinomas, which are rare tumors causing hyperinsulinemic hypoglycemia are usually sporadic but may also occur in association with multiple endocrine neoplasia type 1 (MEN-1) syndrome an autosomal dominant disorder caused by MEN1 gene mutations. MEN1 encodes a nuclear protein Menin, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jyotsna, Viveka P., Malik, Ekta, Birla, Shweta, Sharma, Arundhati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549893/
https://www.ncbi.nlm.nih.gov/pubmed/26307114
http://dx.doi.org/10.1186/s12902-015-0041-2
_version_ 1782387373586251776
author Jyotsna, Viveka P.
Malik, Ekta
Birla, Shweta
Sharma, Arundhati
author_facet Jyotsna, Viveka P.
Malik, Ekta
Birla, Shweta
Sharma, Arundhati
author_sort Jyotsna, Viveka P.
collection PubMed
description BACKGROUND: Insulinomas, which are rare tumors causing hyperinsulinemic hypoglycemia are usually sporadic but may also occur in association with multiple endocrine neoplasia type 1 (MEN-1) syndrome an autosomal dominant disorder caused by MEN1 gene mutations. MEN1 encodes a nuclear protein Menin, a tumor suppressor which acts as an adapter and interacts with partner proteins involved in crucial activities like transcriptional regulation, cell division, proliferation and genome stability. This study reports on clinical findings and mutation screening in sporadic insulinoma patients. METHODS: Seventeen patients diagnosed with insulinoma were recruited along with 30 healthy volunteers who acted as controls for the present study. The patients presented with symptoms of sweating, tremors, drowsiness, palpitations, loss of consciousness, abnormal behavior, seizures and weight gain. Detailed clinical and family history was collected from all the participants along with 5 ml of blood sample after taking informed consent. Genomic DNA isolated from blood was subjected to MEN1 gene amplification followed by direct sequencing. Nucleotide sequences obtained were compared with published MEN1 cDNA sequences. Prediction of functional effects of novel changes was done using various bioinformatics algorithms. RESULTS: Molecular analysis revealed presence of three novel exonic mutations (M561K, Q192K and Q261Q), two novel intronic variations c.445-44G → A and c.913-42G → C in introns two and six respectively and three reported exon SNPs; H433H (rs540012), D418D (rs2071313), A541T (rs2959656) and one intronic SNP (rs669976). CONCLUSIONS: The study identified presence of novel pathogenic MEN1 mutations in sporadic cases of insulinoma. The new mutations identified were in regions involved in defective binding of menin to proteins implicated in genetic and epigenetic mechanisms. The outcome of the study extends the growing list of MEN1 pathogenic mutations even in sporadic cases providing consequential insight into phenotypic heterogeneity and in the expression of individual mutations.
format Online
Article
Text
id pubmed-4549893
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45498932015-08-27 Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study Jyotsna, Viveka P. Malik, Ekta Birla, Shweta Sharma, Arundhati BMC Endocr Disord Research Article BACKGROUND: Insulinomas, which are rare tumors causing hyperinsulinemic hypoglycemia are usually sporadic but may also occur in association with multiple endocrine neoplasia type 1 (MEN-1) syndrome an autosomal dominant disorder caused by MEN1 gene mutations. MEN1 encodes a nuclear protein Menin, a tumor suppressor which acts as an adapter and interacts with partner proteins involved in crucial activities like transcriptional regulation, cell division, proliferation and genome stability. This study reports on clinical findings and mutation screening in sporadic insulinoma patients. METHODS: Seventeen patients diagnosed with insulinoma were recruited along with 30 healthy volunteers who acted as controls for the present study. The patients presented with symptoms of sweating, tremors, drowsiness, palpitations, loss of consciousness, abnormal behavior, seizures and weight gain. Detailed clinical and family history was collected from all the participants along with 5 ml of blood sample after taking informed consent. Genomic DNA isolated from blood was subjected to MEN1 gene amplification followed by direct sequencing. Nucleotide sequences obtained were compared with published MEN1 cDNA sequences. Prediction of functional effects of novel changes was done using various bioinformatics algorithms. RESULTS: Molecular analysis revealed presence of three novel exonic mutations (M561K, Q192K and Q261Q), two novel intronic variations c.445-44G → A and c.913-42G → C in introns two and six respectively and three reported exon SNPs; H433H (rs540012), D418D (rs2071313), A541T (rs2959656) and one intronic SNP (rs669976). CONCLUSIONS: The study identified presence of novel pathogenic MEN1 mutations in sporadic cases of insulinoma. The new mutations identified were in regions involved in defective binding of menin to proteins implicated in genetic and epigenetic mechanisms. The outcome of the study extends the growing list of MEN1 pathogenic mutations even in sporadic cases providing consequential insight into phenotypic heterogeneity and in the expression of individual mutations. BioMed Central 2015-08-26 /pmc/articles/PMC4549893/ /pubmed/26307114 http://dx.doi.org/10.1186/s12902-015-0041-2 Text en © Jyotsna et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jyotsna, Viveka P.
Malik, Ekta
Birla, Shweta
Sharma, Arundhati
Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
title Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
title_full Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
title_fullStr Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
title_full_unstemmed Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
title_short Novel MEN 1 gene findings in rare sporadic insulinoma—a case control study
title_sort novel men 1 gene findings in rare sporadic insulinoma—a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549893/
https://www.ncbi.nlm.nih.gov/pubmed/26307114
http://dx.doi.org/10.1186/s12902-015-0041-2
work_keys_str_mv AT jyotsnavivekap novelmen1genefindingsinraresporadicinsulinomaacasecontrolstudy
AT malikekta novelmen1genefindingsinraresporadicinsulinomaacasecontrolstudy
AT birlashweta novelmen1genefindingsinraresporadicinsulinomaacasecontrolstudy
AT sharmaarundhati novelmen1genefindingsinraresporadicinsulinomaacasecontrolstudy